Pegylated Interferon to Treat Chronic Hepatitis D

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

May 31, 2012

Study Completion Date

October 31, 2012

Conditions
Hepatitis D
Interventions
DRUG

Peginterferon Alpha-2a

Treatment

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00023322 - Pegylated Interferon to Treat Chronic Hepatitis D | Biotech Hunter | Biotech Hunter